Recent advances in understanding depression in adults with diabetes

Current Diabetes Reports

Volumn 7, Issue 2, 2007, Pages 114-122

  Lustman, Patrick J ^a   Penckofer, Sue M ^b   Clouse, Ray E ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; FLUOXETINE; GLUCOSE; IMIPRAMINE; NORTRIPTYLINE; PLACEBO; SERTRALINE;

BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIABETOGENESIS; DIET RESTRICTION; DIET THERAPY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAINTENANCE THERAPY; MAJOR DEPRESSION; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; RECURRENCE RISK; REVIEW; RISK FACTOR; SEXUAL DYSFUNCTION;

ADULT; BLOOD GLUCOSE; DEPRESSION; DIABETES MELLITUS, TYPE 2; HUMANS;

EID: 34248355133     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-007-0020-8     Document Type: Review

References (48)

1. Relman AS, Angell M: Resolved: psychosocial interventions can improve clinical outcomes in organic disease (con). Psychosom Med 2002, 64:558-563.
2. Willis T, ed: Diabetes: A Medical Odyssey. New York: Tuckahoe; 1971.
3. Winokur A, Maislin G, Phillips JL, Amsterdam JD: Insulin resistance after oral glucose tolerance testing in patients with major depression. Am J Psychiatry 1988, 145:325-330.
4. Turkington RW: Depression masquerading as diabetic neuropathy. JAMA 1980, 243:1147-1150.
5. Feighner JP, Robins E, Guze SB, et al.: Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972, 26:57-63.
6. Eaton WW, Armenian HA, Gallo J, et al.: Depression and risk for onset of type II diabetes: a prospective population-based study. Diabetes Care 1996, 19:1097-1102.
7. Lustman PJ, Griffith LS, Gavard JA, Clouse RE: Depression in adults with diabetes. Diabetes Care 1992, 15:1631-1639.
8. Lustman PJ, Clouse RE: Treatment of depression in diabetes: impact on mood and medical outcome. J Psychosom Res 2002, 53:917-924.
9. Knol MJ, Twisk JW, Beekman AT, et al.: Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006, 49:837-845.
10. Clouse RE, Lustman PJ, Freedland KE, et al.: Depression and coronary heart disease in women with diabetes. Psychosom Med 2003, 65:376-383.
11. Saydah SH, Eberhardt MS, Loria CM, Brancati FL: Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol 2002, 156:714-719.
12. Glass GV: Primary, secondary, and meta-analysis of research. Educ Researcher 1976, 5:3-8.
13. Rosenthal R, ed: Meta-analytic Procedures for Social Research. Beverly Hills, CA: Sage Press; 1984.
14. Hunter JE, Schmidt FL, Jackson GB, eds: Meta-analysis: Cumulating Research Findings Across Studies. Beverly Hills, CA: Sage Press, 1982.
15. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001, 24:1069-1078.
16. Lustman PJ, Anderson RJ, Freedland KE, et al.: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000, 23:434-442.
17. de Groot M, Anderson RJ, Freedland KE, et al.: Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001, 63:619-630.
18. Lustman PJ, Griffith LS, Clouse RE, et al.: Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997, 59:241-250.
19. Lustman PJ, Clouse RE, Nix BD, et al.: Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2006, 63:521-529.
20. Williams MM, Clouse RE, Nix BD, et al.: Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes. Diabetes Care 2007, in press.
21. Lustman PJ, Clouse RE, Sayuk GS, et al.: Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care 2007, in press.
22. Steinbrook R: Facing the diabetes epidemic - mandatory reporting of glycosylated hemoglobin values in New York City. N Engl J Med 2006, 354:545-548.
23. Narayan KM, Boyle JP, Thompson TJ, et al.: Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290:1884-1890.
24. American Diabetes Association: Standards of medical care in diabetes - 2007. Diabetes Care 2007 30(suppl 1):S4-S41.
25. Kawakami N, Takatsuka N, Shimizu H, Ishibashi H: Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999, 22:1071-1076.
26. Everson-Rose SA, Meyer PM, Powell LH, et al.: Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 2004, 27:2856-2862.
27. Arroyo C, Hu FB, Ryan LM, et al.: Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 2004, 27:129-133.
28. Stewart AL, Hays RD, Ware JE Jr: The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988, 26:724-735.
29. Golden SH, Williams JE, Ford DE, et al.: Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2004, 27:429-435.
30. Carnethon MR, Kinder LS, Fair JM, et al.: Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971-1992. Amer J Epidemiol 2003, 158:416-423.
31. Symons MJ, Moore DT: Hazard rate ratio and prospective epidemiological studies. J Clin Epidemiol 2002, 55:893-899.
32. Walter SD: Choice of effect measure for epidemiological data. J Clin Epidemiol 2000, 53:931-939.
33. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
34. van den Akker, Schuurman A, Metsemakers J, Buntinx F: Is depression related to subsequent diabetes mellitus? Acta Psychiatr Scand 2004, 110:178-183.
35. Palinkas LA, Lee PP, Barrett-Connor E: A prospective study of type 2 diabetes and depressive symptoms in the elderly: the Rancho Bernardo Study. Diabet Med 2004, 21:1185-1191.
36. Kumari M, Head J, Marmot M: Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Arch Intern Med 2004, 164:1873-1880.
37. Lustman PJ, Clouse RE: Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 2005, 19:113-122.
38. Selvin F, Marinopoulos S, Berkenblit G, et al.: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004, 141:421-431.
39. Egede LE, Nietert PJ, Zheng D: Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005, 28:1339-1345.
40. Zhang X, Norris SL, Gregg EW, et al.: Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 2005, 161:652-660.
41. Katon WJ, Rutter C, Simon G, et al.: The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005, 28:2668-2672.
42. National Institutes of Health: Fact Sheet: Type 2 Diabetes. Available at http://www.nih.gov/about/researchresultsforthepublic/ Type2Diabetes.pdf. Accessed January 12, 2007.
43. Lustman PJ, Freedland KE, Griffith LS, Clouse RE: Fluoxetine for depression in diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care 2000, 23:618-623.
44. Lustman PJ, Griffith LS, Freedland KE, et al.: Cognitive behavior therapy for depression in type 2 diabetes: a randomized controlled trial. Ann Intern Med 1998, 129:613-621.
45. Okamura F, Tashiro A, Utumi A, et al.: Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metab Clin Exp 2000, 49:1255-1260.
46. Lustman PJ, Griffith LS, Clouse RE: Depression in adults with diabetes: results of a 5-year follow-up study. Diabetes Care 1988, 11:605-612.
47. Lustman PJ, Griffith LS, Freedland KE, Clouse RE: The course of major depression in diabetes. Gen Hosp Psychiatry 1997, 19:138-143.
48. Katon WJ, Von Korff M, Lin EH, et al.: The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004, 61:1042-1049.